The distinguished roles of ANKRD11 in Ki67-high and -low group suggest a strong disturbance of Ki67 related pathway to ANKRD11 function and highlight the necessity of restrictive administration of HDAC3 inhibitor in luminal A breast cancer. Here, HDAC3 is linked to breast cancer.